Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Metropolis Healthcare Ltd. ( (IN:METROPOLIS) ) has issued an announcement.
Metropolis Healthcare Ltd. has announced that its trading window for designated persons and their immediate relatives will be closed from April 1, 2026, in line with its code of conduct and SEBI’s insider trading regulations. The window will remain shut until 48 hours after the company announces its financial results for the quarter and year ended March 31, 2026, signaling the upcoming results cycle and reinforcing compliance safeguards for market participants.
The board meeting date for approving these financial results will be communicated later by the company, and the exchange has been asked to take this update on record. The move reflects standard governance practice aimed at preventing insider trading around the release of price-sensitive financial information, providing greater transparency and regulatory assurance to investors and other stakeholders.
More about Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. operates in the diagnostics and pathology services industry, providing medical testing and laboratory services across India. The company focuses on offering a range of clinical laboratory tests to patients, doctors, and healthcare institutions, and its shares are listed on both BSE and the National Stock Exchange of India.
Average Trading Volume: 24,105
Technical Sentiment Signal: Sell
Current Market Cap: 89.93B INR
See more data about METROPOLIS stock on TipRanks’ Stock Analysis page.